The U.S. Army Medical Research Acquisition Activity (USAMRAA), on behalf of the US Army Medical Research Institute of Infectious Diseases (USAMRIID), has issued a requirement for brand name or equal Pharmacal Quatricide TB Disinfectant.
The product is a phosphate free tuberculocidal spray disinfectant, effective as a Tuberculocide, Bactericide, Fungicide and virucide.
The selected contractor will supply 75-225 cases of TB disinfectant each month, for use by the Department of Defense medical community. The item is for disinfecting and deodorizing to include nonporous surfaces such as walls and floors.
USAMRIID plans to conduct a Technical Evaluation of samples provided from all interested offerors submitting a proposal.
Further details are available via Solicitation Number: W81XWH-15-T-0271. The response deadline is Aug. 7, 2015.
